Data collected throughout the duration of a clinical trial can amount to tens of thousands, or even hundreds of thousands of data points; which require expert interpretation and analysis to determine the efficacy, tolerability and safety profile of an investigational drug. Continuous monitoring and interpretation of these raw data are critical in maintaining patients' safety. Realising this, however, has proved a significant challenge, due to the requirement to manually aggregate patient and population data to compile differing clinical data types (e.g. Adverse Events (AEs) and laboratory measurements) over multiple time-points. Additional data challenges are identified in the data formatting and presentation, which is required for successful and accurate interpretation. Furthermore, once a clinical trial has finished, analysis and interpretation of the validated data is mandatory.
